Europe Immunoglobulin Map

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10293087" target="_blank" >RIV/00064203:_____/14:10293087 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/14:10293087
Result on the web
<a href="http://dx.doi.org/10.1111/cei.12546" target="_blank" >http://dx.doi.org/10.1111/cei.12546</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/cei.12546" target="_blank" >10.1111/cei.12546</a>

Result language
angličtina
Original language name
Europe Immunoglobulin Map
Original language description
The European Society for Immunodeficiencies (ESID) Primary Immunodeficiencies Care in Development Working Party was founded in order to improve diagnosis and care of patients with primary immunodeficiencies (PIDs). Immunoglobulins (Ig) are used as a replacement therapy in PIDs associated with deficiencies of antibody production [1]. The Working Party initiated a pan-European survey on the use and availability of Ig preparations in European countries for treatment of PIDs, which resulted in the Europe Immunoglobulin Map. In each European country, one contact person was appointed to answer the survey questionnaire. Work on the map was initiated in 2006, and since 2011 a regular survey has reflected the development in Ig usage all over Europe. To date, wehave information from 35 European countries. The survey brings a unique and interesting view regarding Ig treatment for PIDs in individual European countries, and further shows the trends and changes in this area. Since 2012 the use of I
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)